featured
Safety and Efficacy of Docetaxel Plus Lobaplatin or Gemcitabine for Recurrent and Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Medicine (Baltimore)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pilot Study of Docetaxel Combined With Lobaplatin or Gemcitabine for Recurrent and Metastatic Breast Cancer
Medicine (Baltimore) 2019 Dec 01;98(52)e18513, F Li, B Wang, M He, J Chang, J Li, L Shan, H Wang, W Hong, D Luo, Y Song, L Liu, H Li, L Ran, T ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.